United States · Bill · HR
H.R. 5133 (116th)
Affordable Prescriptions for Patients Through Promoting Competition Act of 2019
Introduced
18 November 2019
Last action
—
Status
Placed on the Union Calendar, Calendar No. 578.
Sponsors
—
Subjects
Discovery layer
Source updated
7 April 2025
Summary
Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 This bill prohibits, subject to certain exceptions, the practice of product hopping, which is presumed when a drug manufacturer obtains removal of a drug from the Food and Drug Administration's approved drug list, discontinues a drug, or markets a reformulation of an already approved drug during a certain period after which the manufacturer has been notified that a competing drug manufacturer has applied for generic drug approval.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
6 official files
Reported in House (text)
Reported in House (text)
Reported in House · EN · 24 December 2020
Reported in House (PDF)
Reported in House · EN · 24 December 2020
Reported to House
summary · EN · 24 December 2020
Introduced in House (text)
Introduced in House · EN · 18 November 2019
Introduced in House (PDF)
Introduced in House · EN · 18 November 2019
Introduced in House
summary · EN · 18 November 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/house-bill/5133
- Open data entity: https://api.congress.gov/v3/bill/116/hr/5133